Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Jul 1;317(Pt 1):109–118. doi: 10.1042/bj3170109

Stimulation of phosphatidylinositol hydrolysis, protein kinase C translocation, and mitogen-activated protein kinase activity by bradykinin in rat ventricular myocytes: dissociation from the hypertrophic response.

A Clerk 1, J Gillespie-Brown 1, S J Fuller 1, P H Sugden 1
PMCID: PMC1217450  PMID: 8694751

Abstract

In ventricular myocytes cultured from neonatal rat hearts, bradykinin (BK), kallidin or BK(1-8) [(Des-Arg9)BK] stimulated PtdinsP2 hydrolysis by 3-4-fold. EC50 values were 6 nM (BK), 2 nM (kallidin), and 14 microM [BK(1-8)]. BK or kallidin stimulated the rapid (less than 30 s) translocation of more than 80% of the novel protein kinase C (PKC) isoforms nPKC-delta and nPKC-epsilon from the soluble to the particulate fraction. EC50 values for nPKC-delta translocation by BK or kallidin were 10 and 2 nM respectively. EC50 values for nPKC-epsilon translocation by BK or kallidin were 2 and 0.6 nM respectively. EC50 values for the translocation of nPKC-delta and nPKC-epsilon by BK(1-8) were more than 5 microM. The classical PKC, cPKC-alpha, and the atypical PKC, nPKC-zeta, did not translocate. BK caused activation and phosphorylation of p42-mitogen-activated protein kinase (MAPK) (maximal at 3-5 min, 30-35% of p42-MAPK phosphorylated). p44-MAPK was similarly activated. EC50 values for p42/p44-MAPK activation by BK were less than 1 nM whereas values for BK(1-8) were more than 10 microM. The order of potency [BK approximately equal to kallidin >> BK (1-8)] for the stimulation of PtdInsP2 hydrolysis, nPKC-delta and nPKC-epsilon translocation, and p42/p44-MAPK activities suggests involvement of the B2 BK receptor subtype. In addition, stimulation of all three processes by BK was inhibited by the B2BK receptor-selective antagonist HOE140 but not by the B1-selective antagonist Leu8BK(1-8). Exposure of cells to phorbol 12-myristate 13-acetate for 24 h inhibited subsequent activation of p42/p44-MAPK by BK suggesting participation of nPKC (and possibly cPKC) isoforms in the activation process. Thus, like hypertrophic agents such as endothelin-1 (ET-1) and phenylephrine (PE), BK activates PtdInsP2 hydrolysis, translocates nPKC-delta, and nPKC-epsilon, and activates p42/p44-MAPK. However, in comparison with ET-1 and PE, BK was only weakly hypertrophic as assessed by cell morphology and patterns of gene expression. This difference could not be attributed to dissimilarities between the duration of activation of p42/p44-MAPK by BK or ET-1. Thus activation of these signalling pathways alone may be insufficient to induce a powerful hypertrophic response.

Full Text

The Full Text of this article is available as a PDF (915.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdellatif M., MacLellan W. R., Schneider M. D. p21 Ras as a governor of global gene expression. J Biol Chem. 1994 Jun 3;269(22):15423–15426. [PubMed] [Google Scholar]
  2. Allen I. S., Cohen N. M., Dhallan R. S., Gaa S. T., Lederer W. J., Rogers T. B. Angiotensin II increases spontaneous contractile frequency and stimulates calcium current in cultured neonatal rat heart myocytes: insights into the underlying biochemical mechanisms. Circ Res. 1988 Mar;62(3):524–534. doi: 10.1161/01.res.62.3.524. [DOI] [PubMed] [Google Scholar]
  3. Bathon J. M., Proud D. Bradykinin antagonists. Annu Rev Pharmacol Toxicol. 1991;31:129–162. doi: 10.1146/annurev.pa.31.040191.001021. [DOI] [PubMed] [Google Scholar]
  4. Berridge M. J., Dawson R. M., Downes C. P., Heslop J. P., Irvine R. F. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem J. 1983 May 15;212(2):473–482. doi: 10.1042/bj2120473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berridge M. J. Inositol trisphosphate and calcium signalling. Nature. 1993 Jan 28;361(6410):315–325. doi: 10.1038/361315a0. [DOI] [PubMed] [Google Scholar]
  6. Bogoyevitch M. A., Glennon P. E., Andersson M. B., Clerk A., Lazou A., Marshall C. J., Parker P. J., Sugden P. H. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem. 1994 Jan 14;269(2):1110–1119. [PubMed] [Google Scholar]
  7. Bogoyevitch M. A., Glennon P. E., Sugden P. H. Endothelin-1, phorbol esters and phenylephrine stimulate MAP kinase activities in ventricular cardiomyocytes. FEBS Lett. 1993 Feb 15;317(3):271–275. doi: 10.1016/0014-5793(93)81291-7. [DOI] [PubMed] [Google Scholar]
  8. Bogoyevitch M. A., Parker P. J., Sugden P. H. Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-epsilon is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothelin. Circ Res. 1993 Apr;72(4):757–767. doi: 10.1161/01.res.72.4.757. [DOI] [PubMed] [Google Scholar]
  9. Bogoyevitch M. A., Sugden P. H. The role of protein kinases in adaptational growth of the heart. Int J Biochem Cell Biol. 1996 Jan;28(1):1–12. doi: 10.1016/1357-2725(95)00142-5. [DOI] [PubMed] [Google Scholar]
  10. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  11. Brand T., MacLellan W. R., Schneider M. D. A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain. J Biol Chem. 1993 Jun 5;268(16):11500–11503. [PubMed] [Google Scholar]
  12. Cherrington J. M., Mocarski E. S. Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. J Virol. 1989 Mar;63(3):1435–1440. doi: 10.1128/jvi.63.3.1435-1440.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chien K. R., Knowlton K. U., Zhu H., Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 1991 Dec;5(15):3037–3046. doi: 10.1096/fasebj.5.15.1835945. [DOI] [PubMed] [Google Scholar]
  14. Clark K. J., Murray A. W. Evidence that the bradykinin-induced activation of phospholipase D and of the mitogen-activated protein kinase cascade involve different protein kinase C isoforms. J Biol Chem. 1995 Mar 31;270(13):7097–7103. doi: 10.1074/jbc.270.13.7097. [DOI] [PubMed] [Google Scholar]
  15. Clerk A., Bogoyevitch M. A., Anderson M. B., Sugden P. H. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J Biol Chem. 1994 Dec 30;269(52):32848–32857. [PubMed] [Google Scholar]
  16. Clerk A., Bogoyevitch M. A., Fuller S. J., Lazou A., Parker P. J., Sugden P. H. Expression of protein kinase C isoforms during cardiac ventricular development. Am J Physiol. 1995 Sep;269(3 Pt 2):H1087–H1097. doi: 10.1152/ajpheart.1995.269.3.H1087. [DOI] [PubMed] [Google Scholar]
  17. Farmer S. G., Burch R. M. Biochemical and molecular pharmacology of kinin receptors. Annu Rev Pharmacol Toxicol. 1992;32:511–536. doi: 10.1146/annurev.pa.32.040192.002455. [DOI] [PubMed] [Google Scholar]
  18. Gillespie-Brown J., Fuller S. J., Bogoyevitch M. A., Cowley S., Sugden P. H. The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes. J Biol Chem. 1995 Nov 24;270(47):28092–28096. doi: 10.1074/jbc.270.47.28092. [DOI] [PubMed] [Google Scholar]
  19. Gohlke P., Linz W., Schölkens B. A., Kuwer I., Bartenbach S., Schnell A., Unger T. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension. 1994 Apr;23(4):411–418. doi: 10.1161/01.hyp.23.4.411. [DOI] [PubMed] [Google Scholar]
  20. Goto M., Liu Y., Yang X. M., Ardell J. L., Cohen M. V., Downey J. M. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 1995 Sep;77(3):611–621. doi: 10.1161/01.res.77.3.611. [DOI] [PubMed] [Google Scholar]
  21. Hall J. M. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther. 1992 Nov;56(2):131–190. doi: 10.1016/0163-7258(92)90016-s. [DOI] [PubMed] [Google Scholar]
  22. Hess J. F., Borkowski J. A., Young G. S., Strader C. D., Ransom R. W. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun. 1992 Apr 15;184(1):260–268. doi: 10.1016/0006-291x(92)91187-u. [DOI] [PubMed] [Google Scholar]
  23. Ito H., Hirata Y., Hiroe M., Tsujino M., Adachi S., Takamoto T., Nitta M., Taniguchi K., Marumo F. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res. 1991 Jul;69(1):209–215. doi: 10.1161/01.res.69.1.209. [DOI] [PubMed] [Google Scholar]
  24. Iwaki K., Sukhatme V. P., Shubeita H. E., Chien K. R. Alpha- and beta-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an alpha 1-mediated response. J Biol Chem. 1990 Aug 15;265(23):13809–13817. [PubMed] [Google Scholar]
  25. Jones M. J., Murray A. W. Evidence that ceramide selectively inhibits protein kinase C-alpha translocation and modulates bradykinin activation of phospholipase D. J Biol Chem. 1995 Mar 10;270(10):5007–5013. doi: 10.1074/jbc.270.10.5007. [DOI] [PubMed] [Google Scholar]
  26. Kameshita I., Fujisawa H. A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal Biochem. 1989 Nov 15;183(1):139–143. doi: 10.1016/0003-2697(89)90181-4. [DOI] [PubMed] [Google Scholar]
  27. Knowlton K. U., Baracchini E., Ross R. S., Harris A. N., Henderson S. A., Evans S. M., Glembotski C. C., Chien K. R. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression. J Biol Chem. 1991 Apr 25;266(12):7759–7768. [PubMed] [Google Scholar]
  28. Lawson C. S., Downey J. M. Preconditioning: state of the art myocardial protection. Cardiovasc Res. 1993 Apr;27(4):542–550. doi: 10.1093/cvr/27.4.542. [DOI] [PubMed] [Google Scholar]
  29. Lazou A., Fuller S. J., Bogoyevitch M. A., Orfali K. A., Sugden P. H. Characterization of stimulation of phosphoinositide hydrolysis by alpha 1-adrenergic agonists in adult rat hearts. Am J Physiol. 1994 Sep;267(3 Pt 2):H970–H978. doi: 10.1152/ajpheart.1994.267.3.H970. [DOI] [PubMed] [Google Scholar]
  30. Lee H. R., Henderson S. A., Reynolds R., Dunnmon P., Yuan D., Chien K. R. Alpha 1-adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells. Effects on myosin light chain-2 gene expression. J Biol Chem. 1988 May 25;263(15):7352–7358. [PubMed] [Google Scholar]
  31. Leevers S. J., Marshall C. J. Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 1992 Feb;11(2):569–574. doi: 10.1002/j.1460-2075.1992.tb05088.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Li K., Chen X. Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat. J Mol Cell Cardiol. 1987 Sep;19(9):909–915. doi: 10.1016/s0022-2828(87)80619-3. [DOI] [PubMed] [Google Scholar]
  33. Limatola C., Schaap D., Moolenaar W. H., van Blitterswijk W. J. Phosphatidic acid activation of protein kinase C-zeta overexpressed in COS cells: comparison with other protein kinase C isotypes and other acidic lipids. Biochem J. 1994 Dec 15;304(Pt 3):1001–1008. doi: 10.1042/bj3041001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Linz W., Wiemer G., Gohlke P., Unger T., Schölkens B. A. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. 1995 Mar;47(1):25–49. [PubMed] [Google Scholar]
  35. Liu Y., Downey J. M. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol. 1992 Oct;263(4 Pt 2):H1107–H1112. doi: 10.1152/ajpheart.1992.263.4.H1107. [DOI] [PubMed] [Google Scholar]
  36. Lozano J., Berra E., Municio M. M., Diaz-Meco M. T., Dominguez I., Sanz L., Moscat J. Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. J Biol Chem. 1994 Jul 29;269(30):19200–19202. [PubMed] [Google Scholar]
  37. MacLellan W. R., Lee T. C., Schwartz R. J., Schneider M. D. Transforming growth factor-beta response elements of the skeletal alpha-actin gene. Combinatorial action of serum response factor, YY1, and the SV40 enhancer-binding protein, TEF-1. J Biol Chem. 1994 Jun 17;269(24):16754–16760. [PubMed] [Google Scholar]
  38. Marshall C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995 Jan 27;80(2):179–185. doi: 10.1016/0092-8674(95)90401-8. [DOI] [PubMed] [Google Scholar]
  39. Matsuki T., Shoji T., Yoshida S., Kudoh Y., Motoe M., Inoue M., Nakata T., Hosoda S., Shimamoto K., Yellon D. Sympathetically induced myocardial ischaemia causes the heart to release plasma kinin. Cardiovasc Res. 1987 Jun;21(6):428–432. doi: 10.1093/cvr/21.6.428. [DOI] [PubMed] [Google Scholar]
  40. McEachern A. E., Shelton E. R., Bhakta S., Obernolte R., Bach C., Zuppan P., Fujisaki J., Aldrich R. W., Jarnagin K. Expression cloning of a rat B2 bradykinin receptor. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7724–7728. doi: 10.1073/pnas.88.17.7724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Menke J. G., Borkowski J. A., Bierilo K. K., MacNeil T., Derrick A. W., Schneck K. A., Ransom R. W., Strader C. D., Linemeyer D. L., Hess J. F. Expression cloning of a human B1 bradykinin receptor. J Biol Chem. 1994 Aug 26;269(34):21583–21586. [PubMed] [Google Scholar]
  42. Minshall R. D., Nakamura F., Becker R. P., Rabito S. F. Characterization of bradykinin B2 receptors in adult myocardium and neonatal rat cardiomyocytes. Circ Res. 1995 May;76(5):773–780. doi: 10.1161/01.res.76.5.773. [DOI] [PubMed] [Google Scholar]
  43. Mitchell M. B., Meng X., Ao L., Brown J. M., Harken A. H., Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res. 1995 Jan;76(1):73–81. doi: 10.1161/01.res.76.1.73. [DOI] [PubMed] [Google Scholar]
  44. Mombouli J. V., Vanhoutte P. M. Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1995;35:679–705. doi: 10.1146/annurev.pa.35.040195.003335. [DOI] [PubMed] [Google Scholar]
  45. Murry C. E., Jennings R. B., Reimer K. A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 Nov;74(5):1124–1136. doi: 10.1161/01.cir.74.5.1124. [DOI] [PubMed] [Google Scholar]
  46. Nakanishi H., Brewer K. A., Exton J. H. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1993 Jan 5;268(1):13–16. [PubMed] [Google Scholar]
  47. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995 Apr;9(7):484–496. [PubMed] [Google Scholar]
  48. Noda K., Sasaguri M., Ideishi M., Ikeda M., Arakawa K. Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc Res. 1993 Feb;27(2):334–340. doi: 10.1093/cvr/27.2.334. [DOI] [PubMed] [Google Scholar]
  49. Nolly H., Carbini L. A., Scicli G., Carretero O. A., Scicli A. G. A local kallikrein-kinin system is present in rat hearts. Hypertension. 1994 Jun;23(6 Pt 2):919–923. doi: 10.1161/01.hyp.23.6.919. [DOI] [PubMed] [Google Scholar]
  50. Nolly H., Carretero O. A., Scicli A. G. Kallikrein release by vascular tissue. Am J Physiol. 1993 Oct;265(4 Pt 2):H1209–H1214. doi: 10.1152/ajpheart.1993.265.4.H1209. [DOI] [PubMed] [Google Scholar]
  51. Parker T. G., Chow K. L., Schwartz R. J., Schneider M. D. Positive and negative control of the skeletal alpha-actin promoter in cardiac muscle. A proximal serum response element is sufficient for induction by basic fibroblast growth factor (FGF) but not for inhibition by acidic FGF. J Biol Chem. 1992 Feb 15;267(5):3343–3350. [PubMed] [Google Scholar]
  52. Parratt J. R. Possibilities for the pharmacological exploitation of ischaemic preconditioning. J Mol Cell Cardiol. 1995 Apr;27(4):991–1000. doi: 10.1016/0022-2828(95)90068-3. [DOI] [PubMed] [Google Scholar]
  53. Parratt J. R. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci. 1994 Jan;15(1):19–25. doi: 10.1016/0165-6147(94)90129-5. [DOI] [PubMed] [Google Scholar]
  54. Pelech S. L., Meier K. E., Krebs E. G. Rapid microassay for protein kinase C translocation in Swiss 3T3 cells. Biochemistry. 1986 Dec 30;25(26):8348–8353. doi: 10.1021/bi00374a002. [DOI] [PubMed] [Google Scholar]
  55. Przyklenk K., Kloner R. A. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action. Am Heart J. 1991 May;121(5):1319–1330. doi: 10.1016/0002-8703(91)90134-4. [DOI] [PubMed] [Google Scholar]
  56. Pucéat M., Hilal-Dandan R., Strulovici B., Brunton L. L., Brown J. H. Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes. J Biol Chem. 1994 Jun 17;269(24):16938–16944. [PubMed] [Google Scholar]
  57. Regoli D., Gobeil F., Nguyen Q. T., Jukic D., Seoane P. R., Salvino J. M., Sawutz D. G. Bradykinin receptor types and B2 subtypes. Life Sci. 1994;55(10):735–749. doi: 10.1016/0024-3205(94)00557-5. [DOI] [PubMed] [Google Scholar]
  58. Rubin L. E., Levi R. Protective role of bradykinin in cardiac anaphylaxis. Coronary-vasodilating and antiarrhythmic activities mediated by autocrine/paracrine mechanisms. Circ Res. 1995 Mar;76(3):434–440. doi: 10.1161/01.res.76.3.434. [DOI] [PubMed] [Google Scholar]
  59. Rybin V. O., Steinberg S. F. Protein kinase C isoform expression and regulation in the developing rat heart. Circ Res. 1994 Feb;74(2):299–309. doi: 10.1161/01.res.74.2.299. [DOI] [PubMed] [Google Scholar]
  60. Sadoshima J., Izumo S. Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res. 1993 Sep;73(3):413–423. doi: 10.1161/01.res.73.3.413. [DOI] [PubMed] [Google Scholar]
  61. Sadoshima J., Izumo S. Signal transduction pathways of angiotensin II--induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ Res. 1993 Sep;73(3):424–438. doi: 10.1161/01.res.73.3.424. [DOI] [PubMed] [Google Scholar]
  62. Scicli A. G. Increases in cardiac kinins as a new mechanism to protect the heart. Hypertension. 1994 Apr;23(4):419–421. doi: 10.1161/01.hyp.23.4.419. [DOI] [PubMed] [Google Scholar]
  63. Shubeita H. E., McDonough P. M., Harris A. N., Knowlton K. U., Glembotski C. C., Brown J. H., Chien K. R. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J Biol Chem. 1990 Nov 25;265(33):20555–20562. [PubMed] [Google Scholar]
  64. Speechly-Dick M. E., Mocanu M. M., Yellon D. M. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res. 1994 Sep;75(3):586–590. doi: 10.1161/01.res.75.3.586. [DOI] [PubMed] [Google Scholar]
  65. Sugden P. H., Bogoyevitch M. A. Intracellular signalling through protein kinases in the heart. Cardiovasc Res. 1995 Oct;30(4):478–492. [PubMed] [Google Scholar]
  66. Thorburn J., Frost J. A., Thorburn A. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J Cell Biol. 1994 Sep;126(6):1565–1572. doi: 10.1083/jcb.126.6.1565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Tio R. A., de Langen C. D., de Graeff P. A., van Gilst W. H., Bel K. J., Wolters K. G., Mook P. H., van Wijngaarden J., Wesseling H. The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig. Cardiovasc Drugs Ther. 1990 Jun;4(3):695–703. doi: 10.1007/BF01856557. [DOI] [PubMed] [Google Scholar]
  68. Traverse S., Gomez N., Paterson H., Marshall C., Cohen P. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J. 1992 Dec 1;288(Pt 2):351–355. doi: 10.1042/bj2880351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Wall T. M., Sheehy R., Hartman J. C. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther. 1994 Aug;270(2):681–689. [PubMed] [Google Scholar]
  70. Ytrehus K., Liu Y., Downey J. M. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994 Mar;266(3 Pt 2):H1145–H1152. doi: 10.1152/ajpheart.1994.266.3.H1145. [DOI] [PubMed] [Google Scholar]
  71. Zeitlin I. J., Fagbemi S. O., Parratt J. R. Enzymes in normally perfused and ischaemic dog hearts which release a substance with kinin like activity. Cardiovasc Res. 1989 Feb;23(2):91–97. doi: 10.1093/cvr/23.2.91. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES